Details of the Drug

General Information of Drug (ID: DMAZ6TP)

Drug Name
Oglufanide
Synonyms Glufanide disodium; Oglufanide disodium; IM-862; Kaposis sarcoma therapy, Cytran
Indication
Disease Entry ICD 11 Status REF
Bacterial infection 1A00-1C4Z Phase 3 [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C16H19N3O5
Canonical SMILES
C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N
InChI
1S/C16H19N3O5/c17-11(5-6-14(20)21)15(22)19-13(16(23)24)7-9-8-18-12-4-2-1-3-10(9)12/h1-4,8,11,13,18H,5-7,17H2,(H,19,22)(H,20,21)(H,23,24)/t11-,13-/m0/s1
InChIKey
LLEUXCDZPQOJMY-AAEUAGOBSA-N
Cross-matching ID
PubChem CID
100094
ChEBI ID
CHEBI:73512
CAS Number
38101-59-6
UNII
4RHY598T5U
DrugBank ID
DB05779
TTD ID
D02RNS

References

1 ClinicalTrials.gov (NCT00002445) Safety and Effectiveness of an Experimental Drug, IM862, in Treating Kaposi's Sarcoma in AIDS Patients. U.S. National Institutes of Health.